These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37902281)

  • 1. Reforming Pharmacy Benefit Managers - A Review of Bipartisan Legislation.
    Cai C; Rome BN
    N Engl J Med; 2023 Nov; 389(18):1640-1643. PubMed ID: 37902281
    [No Abstract]   [Full Text] [Related]  

  • 2. Policy Recommendations for Pharmacy Benefit Managers to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians.
    Daniel H; Bornstein SS;
    Ann Intern Med; 2019 Dec; 171(11):823-824. PubMed ID: 31711103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacies take uniform price demands to court.
    Moskowitz DB
    J Am Health Policy; 1994; 4(4):24-7. PubMed ID: 10136676
    [No Abstract]   [Full Text] [Related]  

  • 4. The state and consequences of dermatology drug prices in the United States.
    Albrecht J; Lebwohl M; Asgari MM; Bennett DD; Cook A; Evans CC; Green LJ; Hodge JA; Kourosh AS; Maloney ME; Howard LM; Olsen EA; Rosenberg SP; Rubin A; Stough DB; Taylor SC; Brod BA
    J Am Acad Dermatol; 2016 Sep; 75(3):603-605. PubMed ID: 27423978
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceuticals and medical devices: Medicare Part D. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447
    [No Abstract]   [Full Text] [Related]  

  • 6. Employer and Plan Sponsor Views on Pharmacy Reimbursement.
    Stull M; Gupton C
    J Manag Care Spec Pharm; 2020 Jun; 26(6):710-712. PubMed ID: 32463776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contract pharmacies come under 340B scrutiny.
    Traynor K
    Am J Health Syst Pharm; 2014 Apr; 71(8):608-11. PubMed ID: 24688031
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-31. PubMed ID: 28252884
    [No Abstract]   [Full Text] [Related]  

  • 9. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003: implications for health-system pharmacy.
    Meyer BM; Cantwell KM
    Am J Health Syst Pharm; 2004 May; 61(10):1042-51. PubMed ID: 15160781
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical prices and health care reform.
    Zellmer WA
    Am J Hosp Pharm; 1993 May; 50(5):1054. PubMed ID: 8506859
    [No Abstract]   [Full Text] [Related]  

  • 11. Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/TRICARE: inclusion of TRICARE Retail Pharmacy Program in federal procurement of pharmaceuticals.
    Office of the Secretary, Department of Defense (DoD)
    Fed Regist; 2010 Oct; 75(199):63383-98. PubMed ID: 20960975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provider boycotts--a review of the Merck-Medco decision. Merck-Medco Managed Care L.L.C. v. Rite Aid Corporation.
    Becker S
    Health Care Law Mon; 2000 May; ():10-8. PubMed ID: 14743588
    [No Abstract]   [Full Text] [Related]  

  • 13. [Legal, methodical, and economic aspects of organization of pharmacotherapy in a military health service].
    Fisun AIa; Gushchenko VA; Miroshnichenko IuV; Goriachev AB
    Voen Med Zh; 2009 Mar; 330(3):4-11. PubMed ID: 19530450
    [No Abstract]   [Full Text] [Related]  

  • 14. Fresh Approaches to Addressing High Drug Costs.
    Armstrong J; Becker C
    NCSL Legisbrief; 2019 Apr; 27(15):1-2. PubMed ID: 30990598
    [No Abstract]   [Full Text] [Related]  

  • 15. Lawmakers get big picture on pharmacy issues.
    Kertesz L
    AHIP Cover; 2008; 49(6):10, 67, 69. PubMed ID: 19180929
    [No Abstract]   [Full Text] [Related]  

  • 16. Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--consequences for costs and availability.
    Rudholm N
    Health Policy; 2008 Aug; 87(2):258-63. PubMed ID: 18164509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
    Gudiksen KL; King JS
    J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 19. Provider-administered drugs move to specialty pharmacy benefit.
    Manag Care; 2014 Apr; 23(4):49. PubMed ID: 24864535
    [No Abstract]   [Full Text] [Related]  

  • 20. Examining Misaligned Incentives for Payers and Manufacturers in Value-Based Pharmaceutical Contracts.
    Kannarkat JT; Good CB; Kelly E; Parekh N
    J Manag Care Spec Pharm; 2020 Jan; 26(1):63-66. PubMed ID: 31880231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.